1. Lv L, Wu Y, Shi H, Sun X, Deng Z, Huo H, Li R, Liu Y*.Efficacy and safety of chimeric antigen receptor T-cells treatment in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis.Cancer Immunol Immunother.2023.72(1).211-221.SCI |
2. Zhang X, Wu Y, Sun X, Cui Q, Bai X, Dong G, Gao Z, Wang Y, Gao C, Sun S, Ji N, Liu Y*.The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.BMC Cancer.2022.22(1).190.SCI |
3. Liu J, Guo J, Sun X, Liu Y*, Gao C*.Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis. Front Oncol.2022.11.799721.SCI |
4. Sun X, Wu Y, Xing R, Bai X, Qian J, Zhu H, Cui Q, Chen Y, Liu Q, Lai W, Li J, Wang Y, Sun S, Gao C, Ji N, Liu Y*.Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China.Front Oncol.2022.12.792274.SCI |
5. Liu J, Guo J, Sun X, Liu Y*, Gao C*.Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis.Front Oncol.2022.11.799721.SCI |
6. Chen T*, Liu Y, Wang Y, Chang Q, Wu J, Wang Z, Geng D, Yu JT, Li Y, Li XQ, Chen H, Zhuang D, Li J, Wang B, Jiang T, Lyu L, Song Y, Qiu X, Li W, Lin S, Zhang X, Lu D, Lei J, Chen Y*, Mao Y*.Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.J Hematol Oncol.2022.15(1).136.SCI |
7. Xuefei Sun#, Yuchen Wu#, Ruixian Xing, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Yuedan Chen, Qing Liu, Wenyuan Lai, Junhong Li, Yaming Wang, Shengjun Sun, Chunji Gao, Nan Ji, Yuanbo Liu*.Non-myeloablative chemotherapy as consolidation strategy after high-dose methotrexatebased chemoimmunotherapy in patients with primary CNS lymphoma:a retrospective single center study in China.Frontiers in Oncology.2022.12.792274.SCI |
8. Xiaowei Zhang, Yuchen Wu, Xuefei Sun, Qu Cui, Xueyan Bai, Gehong Dong, Zifen Gao, Yaming Wang, Chunji Gao, Shengjun Sun, Nan Ji, Yuanbo Liu*.The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.BMC Cancer.2022. 22. 190.SCI |
9. Lv L, Sun X, Wu Y, Cui Q, Chen Y, Liu Y*.Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis.Front Oncol.2021.11.707285.SCI |
10. Lv L, Liu Y*.Clinical Application of Liquid Biopsy in Non-Hodgkin Lymphoma.Front Oncol.2021.11.658234.SCI |
11. Xiaowei Zhang, Yuanbo Liu*.Targeting the PI3K/AKT/mTOR Signaling Pathway in Primary Central Nervous System Lymphoma: Current Status and Future Prospects.CNS Neurol Disord Drug Targets.2020.19(3).165-173.核心期刊 |
12. Na Shen, Yaming Wang, Xuefei Sun, Xueyan Bai, Jinglan He, Qu Cui, Jun Qian, Hong Zhu, Yuedan Chen, Ruixian Xing, Qing Liu, Yuchen Wu, Junhong Li, Wenyuan Lai, Shengjun Sun, Nan Ji, Yuanbo Liu*.Expression of hypoxia-inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors..Brain and behavio.2020.10(8).e01718.SCI |
13. 陈悦丹,刘焕光,孙雪飞,白雪燕,崔衢,邢瑞娴,王亚明,孙胜军,季楠,刘元波*.伊布替尼联合化疗治疗复发难治原发性中枢神经系统淋巴瘤的初步探讨.中华神经外科杂志.2020.10(36).1047-1051.核心期刊 |
14. Yuchen Wu#, Yaming Wang#, Xuefei Sun, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Ruixian Xing, Yuedan Chen, Qing Liu, Jiayuan Guo, Nan Ji, Shengjun Sun, Yuanbo Liu*.Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population.BMC Neurology.2019.19(1).268-275.SCI |
15. 丁慧,陶荣杰,刘元波*.原发性中枢神经系统淋巴瘤治疗进展.中华肿瘤防治杂志.2018.25(5).375-380.核心期刊 |
16. 张静,田甜,刘静,崔竹梅*,刘元波*.表皮生长因子促进子宫内膜腺癌细胞系增殖.基础医学与临床.2017.37(4).488-492.核心期刊 |
17. Jing Liu#,Yaming Wang#,Xuefei Sun,Shuo Liu,Zhenkun Yu,Nan Ji,Shengjun Sun,Yuanbo Liu*.Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients .Oncology Letters.2017.14(6).8162-8170 .SCI |
18. Xuefei Sun#,Jing Liu#,Yaming Wang,Xueyan Bai,Yuedan Chen,Jun Qian,Hong Zhu,Fusheng Liu,Xiaoguang Qiu,Shengjun Sun,Nan Ji,Yuanbo Liu*.Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma .Oncotarget.2017.8(30).49156-49164.SCI |
19. Jing Liu#, Yaming Wang, Yuantao Liu, Zhe Liu, Qu Cui, Nan Ji, Shengjun Sun, Bingxu Wang, Yajie Wang, Xuefei Sun, Yuanbo Liu*.Immunohistochemical profle and prognostic signifcance in primary central nervous system lymphoma: Analysis of 89 cases.Oncology Letters .2017.14(5).1792-1074 .SCI |
20. Jing Liu, Yaming Wang, Xuefei Sun, Nan Ji, Shengjun Sun, Yajie Wang, Fusheng Liu, Qu Cui, Chen Wang*, Yuanbo Liu*.Promoter methylation attenuated SHP1 expression and function in patients with primary central nervous system lymphoma.Oncology Reports.2017.37(2).887-894.SCI |
21. Xueliang Yang#,Yuanbo Liu*.Advances in Pathobiology of Primary Central Nervous System Lymphoma .Chin Med J.2017.130(16).1973-1979 .SCI |
22. 崔衢,刘静,张静,王雅杰,张勇,崔竹梅,刘元波*.Tyk2促进前列腺癌细胞系雄激素受体特异位点Tyr-267磷酸化.基础医学与临床.2016.36(11).1499-1504.核心期刊 |
23. 孙雪飞,刘静,孙胜军,王亚明,陈悦丹,邢瑞娴,白雪燕,钱筠,朱红,季楠,刘元波.利妥昔单抗联合化疗方案治疗原发性中枢神经系统淋巴瘤的疗效.中华神经外科杂志.2016.32(4).388-392.核心期刊 |
24. 刘静,陈悦丹,张静,王雅杰,张勇,刘元波*.达沙替尼抑制前列腺癌细胞雄激素受体磷酸化机制研究.肿瘤研究与临床.2016.28(6).361-365.核心期刊 |
25. 刘元波*.中美医学教育与住院培训解析.继续医学教育.2016.30(3).6-8.核心期刊 |
26. Ruifang Mi,Chunxiao Pan,Yiqing Zhou,Yuanbo Liu, Guishan Jin,Fusheng Liu.Identification of the metastasis potential and its associated genes in melanoma multinucleated giant cells using the PHA-ECM830 fusion method.Oncology Reports.2016.35(1).211-218.SCI |
27. Jun Qian, Qu Cui, Yuanbo Liu*.Isolated primary intracranial myeloid sarcoma with neuromeningeal infiltration:A case report.Oncol Lett.2015.9(2).1647-1650.SCI |
28. Xueyan Bai, Qu Cui,Yuanbo Liu*.Interstitial pneumonitis related to rituximab therapy for Waldenstrom's macroglobulinimia.. Clinical Case Reports.2015.3(2).133-134.SCI |
29. 刘静,王亚明,刘元波*.原发性中枢神经系统淋巴瘤分子病理机制的研究进展.国际输血与血液学杂志.2015.38(4).325-329.核心期刊 |
30. Jing Liu, Xuefei Sun, Jun Qian, Xueyan Bai, Hong Zhu, Qu Cui, Xiaoyan Li, Yuedan Chen, Yaming Wang and Yuanbo liu*.Immunochemotherapy for primary central nervous system lymphoma with rituximab,methotrexate, cytarabine and dexamethasone:Retrospective analysis of 18 cases.Molecular and Clinical Oncology.2015.3(4).949-953.SCI |
31. Mehmet Karaca, Yuanbo Liu#, Zhentao Zhang Zhang, Dinuca De Silva, Joel S,Parker, H.Shelton Earp, Young E. Whang.Mutation of androgen receptor N-terminal phosphorylation site Tyr-267 leads to inhibition of nuclear translocation and DNA binding.PLOS ONE.2015.10(5).e0126270.SCI |
32. 孙雪飞,赵晖,李扬,钱筠,白雪燕,周永建,张勇,刘元波*.无雄激素条件下表皮生长因子诱导前列腺癌细胞增殖及雄激素受体磷酸化.基础医学与临床.2014.34(3).305-309.核心期刊 |
33. 李扬,刘福生,刘元波*,张俊庭.原发性中枢神经系统淋巴瘤的诊断与治疗.中华血液学杂志.2014.35(8).771-773.核心期刊 |
34. Liu Y, Karaca M, Zhang Z, Gioeli D, Earp HS, Whang YE*.Dasatinib inhibit site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src in prostate cancer cells.Oncogene.2010.29(6).3208-3216.SCI |
35. Mahajan NP, Liu Y, Majumder S, Warren MR, Parker CE, Moler JL, Earp HS, Whang YE*.Activated cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.PNAS.2007.104(20).8438-8443.SCI |
36. Majumder S#, Liu Y#, Ford OH, Mohler JL, Whang YE*.Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viabilit.The Prostate.2006.66(12).1292-1301.SCI |
37. Gregory CW*, Whang YE, McCall W, FeiX, Liu Y, Ponguta LA,French FS, Wilson EM, Earp HS 3rd..Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.Clinical Cancer Research.2005.11(5).1704-1712.SCI |
38. Liu Y, Majumder S, Mccall W, Sartor CI, Mohler JL, Gregory CW, Earp HS, Whang YE.Inhibition of HER2/NEW kinase impair androgen receptor recruitment to the androgen responsive enhancer.Cancer Research.2005.65(8).3404-3409.SCI |
39. Whang YE*, Yuan XJ,Liu Y,Majumder S, Lewis TD.Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.Vitam Horm..2004.67.409-26.SCI |
40. Chao, H, Monahan, P, Liu, Y, Samulski, R and Walsh, C.Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors..Molecular Therapy .2001.4.217-222.SCI |
41. Hengjun Chao,Yuanbo Liu,Joseph Rabinowitz,Chengwen Li, Richard Jude samulski and ChristopherE.Walsh.Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype Vectors.Molecular Therapy .2000.2.619-623.SCI |
42. Xu Kailin,Hao Yushu,Wu Qing Chao,Liu Yuanbo.Hyperinsulinemia accompanying hyperglycemia in Chinese patients with aplastic anemia.American Journal of Hematology.1997.56(3).151-54.SCI |